Randomised trial spacer v nebuliser for acute asthma.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 7741574.
- Also identified by PMC identifier 1511081.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Sixty hospitalised children with asthma aged 1-5 years were randomised to spacer or nebuliser. A clinical score was measured at baseline and every 12 hours. There were no differences between groups in the score over time, or secondary outcome measures. The spacer is an effective delivery method for young hospitalised asthmatic children.
Medical subject headings
- Albuterol
- Asthma
- Nebulizers and Vaporizers